100% Secure Payments
Tender Details
- Country: United Kingdom
- Summary: Genome Plasmid
- GBT Ref No: 121068504
- Deadline: 01 Jul 2025
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: Public
- Tender Value: 62000.00
- Notice Type: Tender
- Document Ref. No.: JUN532782
- Purchaser's Detail :
- Description :
- We are planning a clinical trial to treat a rare genetic disease that causes progressive dementia in children. Our therapy is based on the following: Autologous haematopoietic stem progenitor cells (HSPCs) are modified ex vivo with a lentiviral vector (LV) to express supraphysiologic levels of a secreted enzyme in myeloid progeny, in essence using gene-modified monocytes/macrophages as a durable and effective vehicle for central nervous system (CNS) enzyme delivery.In order to progress this therapy, we require the following; a plasmid to our specification, produced to FDA, IND ready standard for use in the manufacture of a lentiviral vector for clinical trial. This Plasmid will be delivered directly from the supplier to the University of Edinburgh-s partner in the project, University of California Los Angeles.
Genome Plasmid
Purchaser : University Of Edinburgh
Published : 17/06/2025
Deadline : 2025-07-01 - Documents :
Purchaser : UNIVERSITY OF EDINBURGH
University Of Edinburgh
Charles Stewart House, 9-16 Chambers Street
Edinburgh
EH1 1HT
UK
Telephone: +44 1316502759
Email :jpike2@ed.ac.uk
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
